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Abstract
We introduce an integrated microfluidic device consisting of a biomolecule concentrator and a
microdroplet generator, which enhances the limited sensitivity of low-abundance enzyme assays
by concentrating biomolecules before encapsulating them into droplet microreactors. We used this
platform to detect ultra low levels of matrix metalloproteinases (MMPs) from diluted cellular
supernatant and showed that it significantly (∼10-fold) reduced the time required to complete the
assay and the sample volume used.
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Secreted active proteases, from families of enzymes such as matrix metalloproteinases
(MMPs), participate in diverse biological and pathological processes[1]. As the key
degradative enzymes of the extracellular matrix, MMPs play a critical role in cancer
development and metastasis[2]. However, the activity of these enzymes has been difficult to
measure because of their low abundance, and correspondingly long reaction times necessary
to turn over sufficient substrate for detection[3-5]. Existing enzyme activity assays either lack
the sensitivity required to directly detect the protease activity in limited sample
quantities[6-8] or suffer from low throughput[9-11].
Droplet-based microfluidics has been widely applied to improve many analytical methods in
chemistry and biology[12], such as high-throughput screening[13-15], protein
crystallization[16,17], cell encapsulation[18,19] and enzymatic assays[20,21]. The ability to run
massively parallel reactions in thousands of droplets is desirable in order to monitor the
enzymatic activity of physiological samples using extremely small amounts of sample and
reagents[12,13,15]. However, the analysis of low-abundance enzymes directly from
physiological samples in droplets is challenging because of the low assay sensitivity, the
long assay times and the nonspecific loss of target biomolecules to droplet interfaces.
Random encapsulation of individual biomolecules into droplets could increase the effective
concentration within droplets and enhance the assay sensitivity[18,20-24]. However, this mode
of enhancement is limited because even in the smallest stable droplets (diameter ∼5 μm), a
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single trapped molecule is equivalent to an effective concentration of ∼1pM, which is below
the detection limit of many conventional assays, such as capillary electrophoresis-based
assays[25] and immunoassays[26]. So far, methods for controlling reactant concentrations in
droplets[12,27-32] rely on further dilution of the sample to tune the ratio of the different
reactants. Thus, a reliable and programmable method to increase the concentration of
biomolecules within droplets is required to take advantage of the full potential of droplet-
based microfluidics.
Previously, a nanofluidic biomolecule concentrator based on ion concentration polarization
phenomenon[33] has been developed for trapping and collecting proteins in a sample into a
pL-scale plug. This concentrator exhibits local concentration enhancement up to a
millionfold. This technique has been employed to increase the sensitivity of protein
immunoassays[34], enzyme activity assays[11] and kinase assays using unfractionated cell
lysates[9] without changing the biochemistry involved (e.g., the quality of antibody) in the
assay. However, the localized high concentration sample plug can easily disperse during
downstream processing and observation[35]. Thus, the reactions in these concentration-
enhanced assays are usually run in continuously accumulating plugs[36] (non-equilibrium
reaction), which complicates the interpretation of the results.
Here, we have integrated a biomolecule concentrator and a droplet generator in a single
chip, exploiting the complementary advantages—sensitivity enhancement and effective
encapsulation—of these two technologies. Additionally, the multiplexed assays can be
completed with a minimal amount of sample reagent because numerous droplets that have
different sample concentrations are used as individual reaction chambers. Thus, this
integrated device has the ability to detect low-abundance enzymes and other relevant
biomarkers in complex physiological samples with high sensitivity and throughput, and
therefore can be a generic tool for systems biology research and medical diagnostics. We
used this platform to analyze protease MMP activity directly from cellular supernatants and
demonstrated a significant (∼10-fold) increase in the reaction rate and a consequent
reduction in the reaction time. We used less than 25μL of diluted cellular supernatant to
simultaneously probe up to 10 different reaction conditions, a task that would have been
extremely difficult using existing analytical methods.
The device shown in the schematic diagram (Figure 1A) was fabricated (details in S1) as a
Polydimethylsiloxane (PDMS) chip bonded to a PDMS-coated glass slide. We introduced
three aqueous streams into the device using syringe pumps (Harvard, PHD2000). The
sample in the middle channel contained the target enzyme and a fluorescent tracer (Alexa
Fluor-546 phalloidin, λex=561nm; λem=572nm). The two side channels contained the
substrate for the enzyme activity assays, to be mixed just before droplet formation. The
biomolecule concentrator consisted of polymeric nanoporous (ion-selective) junctions
between the microchannels, and a voltage could be applied using buffer channels on either
side across the planar ion-selective membrane. To concentrate the biomolecules, we applied
a voltage across the main channel (containing the sample) and the side channels (containing
buffer solution) to produce an electrokinetically driven force in the main channel[37-40],
which pushed negatively charged molecules in the opposite direction of the flow.
The sample flow rate (0.03μL/min) and the applied voltage (∼50V) were adjusted so that the
electrokinetic force balanced the pressure-driven flow to trap the biomolecules at the
boundary and continuously accumulate them into a plug. This plug was monitored by the
fluorescence (λex=561nm; λem=572nm) of the added tracer, as shown in Figure 1B. The
enhancement factor of the biomolecule concentration in the plug could be varied by
choosing the concentration time and was tuned to be ∼100-fold. After sufficient
accumulation, the plug was released by turning off the voltage, was transported by pressure-
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driven flow and was mixed with the substrate coming in from the side channels in the
mixing zone (Figure 1C). The mixing ratio of enzyme and substrate was controlled by
adjusting the flow rates of three aqueous streams to ensure a ratio of 1:1 between the
enzyme (sample) and substrate solutions. The plug containing the assay mixture was then
sent to the droplet generator for encapsulation (details in S2, see supporting video) and the
maximum concentration enhancement reduced to ∼20-fold at this stage due to dispersion
during transport and mixing.
A flow-focusing geometry was used as the droplet generator with fluorocarbon oil as the
carrier fluid (Figure 1D). The hydrophobic PDMS surfaces in the device caused the aqueous
solution containing the enzyme-substrate mixtures to lift off and become encapsulated in the
oil, forming a monodisperse water-in-oil emulsion. The oil flow rate was kept at 1.0 μL/min
to match the aqueous flow rates used to form the droplets (∼40pL volume with a generation
rate of ∼2.5kHz). Because the volume of the reaction mixture plug was larger than the
droplet size, the plug was divided into several droplets with different enhanced enzyme
concentrations with a constant substrate concentration (Figure 1F). The enzyme and
substrate spontaneously mixed well as the result of the vortices induced inside the
droplets[41] which were stabilized by dispersing a synthesized biocompatible surfactant
(details in S3) [12,42,43] in the oil phase ensuring that the contents remained isolated for
individual reactions. All droplets were monitored using the tracer fluorescence and reaction
product fluorescence (Figure 1E, details in S4). This scheme enabled the simultaneous
observation of the activities at different enzyme concentrations, resulting in a high assay
throughput.
To characterize the microfluidic platform, we detected and the activity of the β-galactosidase
(details in S5) and the kinase MK2 (details in S6). After these tests, we employed this
platform to study the activity of a recombinant matrix metalloproteinase (MMP-9, 0.2nM) in
MMP buffer using a FRET-based polypeptide MMP substrate (5μM), which fluoresces upon
cleavage as an indicator of proteolytic activity. MMP-9 activity was monitored in the
individual droplets. We observed very small fluorescence changes (∼25a.u.) for the
negative-control samples lacking protease (Figure 2A). For droplets containing the protease,
the fluorescence intensities of the turned-over substrate increased linearly with assay time in
both experiments with and without the concentration step. After the preconcentration step,
the concentration of MMP-9 in the droplets increased up to 16-fold (inferred by the tracer
fluorescence) which correlated with the identical increase in activity measured using product
fluorescence.
Additionally, different enzyme concentrations (from 0.2nM to 3.2nM) were screened in a
single experiment to obtain information on reaction kinetics, as shown in Figure 2B. The
concentration range could be tuned by selecting the distance. As expected, the reaction rates
showed an almost linear increase with increasing MMP-9 concentration. After calibration of
the fluorescence intensity of the product (details in S7), the value of the kinetic constant
(kcat/Km = 7.81*104 M−1 S−1) was obtained by assuming that Michaelis-Menten kinetics
were obeyed. This result was consistent with the value obtained using a standard plate-
reader (details in S8) and with the value from a previous study on protease activity[2].
We then performed the experiments with diluted conditioned media from in vitro tissue
culture samples (0.5× cellular supernatant dilutions in MMP buffer) to study the protease
activity in the media. Specifically, we examined stimulated and untreated protease activity
of the culture media from mouse embryonic fibroblasts (MEF) in response to cytokine
treatment. The details of the cell culture are described further in the supporting information
(details in S9). For both stimulated and untreated samples, the proteolysis reaction caused
the fluorescence intensity to increase linearly over time (Figure 3A). After concentrating the
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sample, the difference in activity between the stimulated and untreated samples was
amplified ∼10-fold compared to difference between the unconcentrated samples. The
detection sensitivity for the stimulated and untreated conditions was thus improved,
allowing us to clearly differentiate these conditions by the slopes of the fluorescence
intensity increase over 5 min (line-1 slope: 2.14a.u./s, line-3 slope: 0.95a.u./s). In the
unconcentrated assay, the traces of the stimulated condition (line-2 slope: 0.32a.u./s) were
significantly different from those of the untreated condition (line-4 slope: 0.22a.u./s) only
after 50 min of reaction time. Taking advantage of the high-throughput screening made
possible by using our device (Figure 3B), the reaction rates over a range of concentration
enhancements were determined by a single experimental run to obtain the parameters related
to the reaction kinetics (stimulated sample: (kcat/KM)[E] = 1.61*10−4S−1; untreated sample:
(kcat/KM)[E] = 4.68*10−5S−1). This experiment required less than 25μL of diluted cellular
supernatant. This is a ∼100-fold reduction in sample volume compared to conventional
assays. More details are shown in the supporting information (details in S10).
In summary, we developed a microfluidic platform that integrates a biomolecule
concentrator and a droplet generator to detect enzyme activity with high sensitivity in a
high-throughput manner. This system can be used to analyze different enzyme reactions,
such as those catalyzed by reporter enzymes, kinases and proteases. We specifically
characterized the activity of MMPs in diluted cellular supernatant from stimulated and
untreated MEF cells. The concentrator amplified the difference between the stimulated and
untreated conditions and allowed a significant reduction in the reaction time (∼10-fold).
Moreover, the protease-substrate reaction kinetics could be determined by a parallel analysis
of droplets with different amplified enzyme concentrations in a single experiment to
significantly reduce the sample volume used (∼100-fold). This device, with its ability to
assay biochemical reactions catalyzed by low-abundance enzymes and other relevant
biomarkers in physiologically complex samples, is a generic and useful platform for systems
biology research and medical diagnostics.
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(A) Schematic representation of the integrated nanofluidic biomolecule concentrator and
microfluidic droplet generator chip. (B) The enzyme molecules were accumulated by a
concentrator into a plug that (C) was mixed with the substrate and (D) then encapsulated
into monodisperse microdroplets for time-dependent observation. (E) The reaction to turn
over the fluorogenic substrate was monitored as a function of time in the droplets. (F) The
scheme shows that the concentrated plug diffuses as it travels from the concentrator to the
point where it is encapsulated in immiscible fluid (∼200μm). Then, the plug is divided into
several droplets with different enzyme concentrations for parallel screening.
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(A) The product fluorescence intensity increase in each individual droplet with reaction time
(after mixing the MMP and the sensor) is shown. The reaction rate exhibited a 15-fold
increase because of the enhancement of the recombinant protease MMP-9 concentration.
The scale bar in the figure is 25μm. (B) In this plot, the reaction rate increased as the MMP
concentration in the droplets increased. The protease concentrations were inferred by
comparing the tracer dye intensity to that of the droplet without enzyme (0.2nM). Different
concentrations were analyzed in a single experiment to obtain the reaction kinetics
constants. Each data point represents the average of five droplets, and the error bar
represents the standard deviation. The scale bar in the figure is 50μm.
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(A) The increase in the product fluorescence intensity in an individual droplet with reaction
time (after mixing the cellular supernatant and the sensor) is shown. The reaction rates, as
determined by substrate turnover resulting from proteolysis in cellular supernatant, were
monitored as a function of time. The activities of the stimulated samples (concentrated and
unconcentrated) are represented by line-1 and line-2, respectively. The activities of untreated
samples are shown in line-3 (concentrated) and line-4 (unconcentrated). The difference in
the reaction rates was greater for the concentrated samples than for the unconcentrated
samples, and thus, the assay sensitivity was improved. (B) The reaction rate increased with
increasing cellular supernatant concentrations in the droplets. A linear relation was observed
between the reaction rate and the initial concentration. Each data point represents the
average of five droplets, and the error bar represents the standard deviation.
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